- Home
- MNPR vs NMG Comparison
MNPR vs NMG Comparison
Compare MNPR & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | NMG |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.0M | 353.7M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MNPR | NMG |
|---|---|---|
| Price | $58.89 | $2.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $101.42 | $4.16 |
| AVG Volume (30 Days) | 220.8K | ★ 1.1M |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.06 | $1.30 |
| 52 Week High | $105.00 | $6.06 |
Technical Indicators
Market Signals| Indicator | MNPR | NMG |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 39.93 |
| Support Level | $56.15 | $1.67 |
| Resistance Level | $61.30 | $3.25 |
| Average True Range (ATR) | 3.99 | 0.17 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 39.19 | 33.91 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.